| Dr Gary M Garner, RPH, MD, FAAHPM | |
|
1055 N 500 W, Suite 202, Provo, UT 84604-3305 | |
| (801) 374-2367 | |
| Not Available |
| Full Name | Dr Gary M Garner |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 1055 N 500 W, Provo, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811067762 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 150719-1205 (Utah) | Secondary |
| 207QH0002X | Family Medicine - Hospice And Palliative Medicine | 1507191205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Icare Hospice | Springville, UT | Hospice |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Utah Cancer Specialists Pc | 1355254749 | 39 |
News Archive
Children's Hospital Boston's Pain Treatment Service has been named a "Clinical Center of Excellence" by the American Pain Society, an honor that is bestowed upon five pain centers each year. This is the first year Children's has entered into the nomination process.
People with type 2 diabetes are at greater risk of serious liver disease than those without the condition, new research has shown.
Responding to a study published in the New England Journal of Medicine, which concluded that lung transplants were harmful for children with cystic fibrosis, articles published in the latest issue of Pediatric Transplantation refute the conclusions and argue that the highly influential research was severely flawed.
China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the year ended December 31, 2011.
Liquidia Technologies, Inc. announced today that it has entered into a collaboration and license agreement with Abbott to develop PRINT nanoparticles for the delivery of siRNA-based therapeutics. Liquidia's PRINT technology offers the ability to fabricate nanoparticles of precisely defined size, shape, surface chemistry, and composition, which offers the potential to develop safer and more effective therapies.
› Verified 3 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Children's Hospital Boston's Pain Treatment Service has been named a "Clinical Center of Excellence" by the American Pain Society, an honor that is bestowed upon five pain centers each year. This is the first year Children's has entered into the nomination process.
People with type 2 diabetes are at greater risk of serious liver disease than those without the condition, new research has shown.
Responding to a study published in the New England Journal of Medicine, which concluded that lung transplants were harmful for children with cystic fibrosis, articles published in the latest issue of Pediatric Transplantation refute the conclusions and argue that the highly influential research was severely flawed.
China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the year ended December 31, 2011.
Liquidia Technologies, Inc. announced today that it has entered into a collaboration and license agreement with Abbott to develop PRINT nanoparticles for the delivery of siRNA-based therapeutics. Liquidia's PRINT technology offers the ability to fabricate nanoparticles of precisely defined size, shape, surface chemistry, and composition, which offers the potential to develop safer and more effective therapies.
› Verified 3 days ago
| Entity Name | Utah Cancer Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619925369 PECOS PAC ID: 1355254749 Enrollment ID: O20031111000618 |
News Archive
Children's Hospital Boston's Pain Treatment Service has been named a "Clinical Center of Excellence" by the American Pain Society, an honor that is bestowed upon five pain centers each year. This is the first year Children's has entered into the nomination process.
People with type 2 diabetes are at greater risk of serious liver disease than those without the condition, new research has shown.
Responding to a study published in the New England Journal of Medicine, which concluded that lung transplants were harmful for children with cystic fibrosis, articles published in the latest issue of Pediatric Transplantation refute the conclusions and argue that the highly influential research was severely flawed.
China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the year ended December 31, 2011.
Liquidia Technologies, Inc. announced today that it has entered into a collaboration and license agreement with Abbott to develop PRINT nanoparticles for the delivery of siRNA-based therapeutics. Liquidia's PRINT technology offers the ability to fabricate nanoparticles of precisely defined size, shape, surface chemistry, and composition, which offers the potential to develop safer and more effective therapies.
› Verified 3 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Children's Hospital Boston's Pain Treatment Service has been named a "Clinical Center of Excellence" by the American Pain Society, an honor that is bestowed upon five pain centers each year. This is the first year Children's has entered into the nomination process.
People with type 2 diabetes are at greater risk of serious liver disease than those without the condition, new research has shown.
Responding to a study published in the New England Journal of Medicine, which concluded that lung transplants were harmful for children with cystic fibrosis, articles published in the latest issue of Pediatric Transplantation refute the conclusions and argue that the highly influential research was severely flawed.
China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the year ended December 31, 2011.
Liquidia Technologies, Inc. announced today that it has entered into a collaboration and license agreement with Abbott to develop PRINT nanoparticles for the delivery of siRNA-based therapeutics. Liquidia's PRINT technology offers the ability to fabricate nanoparticles of precisely defined size, shape, surface chemistry, and composition, which offers the potential to develop safer and more effective therapies.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gary M Garner, RPH, MD, FAAHPM 1264 N 1270 E, American Fork, UT 84003-3520 Ph: (801) 592-8536 | Dr Gary M Garner, RPH, MD, FAAHPM 1055 N 500 W, Suite 202, Provo, UT 84604-3305 Ph: (801) 374-2367 |
News Archive
Children's Hospital Boston's Pain Treatment Service has been named a "Clinical Center of Excellence" by the American Pain Society, an honor that is bestowed upon five pain centers each year. This is the first year Children's has entered into the nomination process.
People with type 2 diabetes are at greater risk of serious liver disease than those without the condition, new research has shown.
Responding to a study published in the New England Journal of Medicine, which concluded that lung transplants were harmful for children with cystic fibrosis, articles published in the latest issue of Pediatric Transplantation refute the conclusions and argue that the highly influential research was severely flawed.
China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the year ended December 31, 2011.
Liquidia Technologies, Inc. announced today that it has entered into a collaboration and license agreement with Abbott to develop PRINT nanoparticles for the delivery of siRNA-based therapeutics. Liquidia's PRINT technology offers the ability to fabricate nanoparticles of precisely defined size, shape, surface chemistry, and composition, which offers the potential to develop safer and more effective therapies.
› Verified 3 days ago
Dr. Robert Joel Bush, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 750 N Freedom Blvd Ste 300, Provo, UT 84601 Phone: 801-852-1443 | |
Janee Namealoha Sells, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3200 N Canyon Rd Ste C, Provo, UT 84604 Phone: 385-375-8724 | |
Dr. Marlin L Christianson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 West 940 North, Provo, UT 84604 Phone: 801-357-7930 Fax: 801-357-7014 | |
Tyson Schwab, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 395 W Bulldog Blvd Ste 205, Provo, UT 84604 Phone: 801-357-1770 | |
Mr. Gregory Lawrence Nielsen, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1750 N Wymount Terrace Dr, Provo, UT 84604 Phone: 801-422-2771 Fax: 801-422-0761 | |
Mr. Tyler Jason Fieldsted, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 W 940 N, Provo, UT 84604 Phone: 801-357-7926 Fax: 801-357-7927 | |
Dr. Matthew Craig Evans, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1157 N 300 W, #201, Provo, UT 84604 Phone: 801-581-2000 |